Wegovy is an injectable weight loss medication containing semaglutide, a GLP-1 receptor agonist that mimics a hormone naturally produced in your intestines
The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes
Ambas ejercen efectos insulino-trpicos dependientes de la glucosa, aunque con diferencias fisiolgicas notables
1000
Instead, it activates the GH secretagogue receptor 1a (GHSR1a), the same receptor that the natural hormone ghrelin binds to
The slowed digestion also helps decrease blood sugar spikes, and the satiety effect of GLP1- agonists reduces food intake, appetite, and hunger